Walleye Capital
KZR

Walleye Capital’s Kezar Life Sciences KZR Stock Holding History

Walleye Capital’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-37,658
Closed -$448K – 5242
2023
Q3 		$448K Sell
37,658
-5,260
-12% -$93.2K ﹤0.01% 2900
2023
Q2 		$1.05M Buy
42,918
+18,044
+73% +$470K ﹤0.01% 1808
2023
Q1 		$779K Buy
+24,874
New +$1.44M 0.01% 1347
2022
Q1 		– Sell
-3,311
Closed -$554K – 2440
2021
Q4 		$554K Buy
+3,311
New +$374K 0.02% 924

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's KZR Position: Q4 2023 in Review

Walleye Capital sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 37,658 shares — an estimated $448K sold.

Walleye Capital first reported a position in KZR in Q4 2021 and held it in 4 quarters. The position peaked at $1.05M in Q2 2023. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • Walleye Capital reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 37,658 Kezar Life Sciences shares in Q4 2023, an estimated $448K.
  • Walleye Capital first reported a position in Kezar Life Sciences in Q4 2021 and held it in 4 quarters.
  • Walleye Capital's Kezar Life Sciences position peaked at $1.05M in Q2 2023.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.